Journal of Functional Foods · 2019 · 88 citations · 34 references
Life SciencesBiochemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyEnzyme InhibitionPeptide ChemistryPeptide Drug DiscoveryProteins In FoodsProteolytic EnzymesProteolytic ProcessingAngiotensin-converting Enzyme Inhibitory PeptidesDigestionDipeptidyl PeptidasesGastrointestinal DigestionPeptidase ActivityPeptide Structure - Activity RelationshipsTherapeutic PeptidesTherapeutic Target Identification
Angiotensin converting enzyme (ACE) and dipeptidyl peptidase IV (DPP-IV) are important membrane peptidases. The inhibition of ACE and DPP-IV enzymes has become a key therapeutic target for the treatment of hypertension and diabetes. This study was conducted to discover membrane peptidase inhibitory peptides that inhibit ACE and DPP-IV. Egg proteins were cleaved by pepsin and trypsin in silico. The potential activity, solubility, absorption, distribution, metabolism, excretion, and toxicity of the peptides were then predicted online. Finally, ACE and DPP-IV were applied as molecular docking targets for the potential peptides. After simulating gastrointestinal digestion, the IC50 values of ADF, MIR, and FGR against ACE activity were 27.75 ± 0.90 mM, 24.97 ± 0.80 mM, and 66.98 ± 1.40 μM, against DPP-IV activity were 16.83 mM, 4.86 mM, and 46.22 mM, respectively. The ACE and DPP-IV inhibitory peptides identified from hen egg proteins can be used as functional food ingredients for controlling hypertension and diabetes.
34
BIOPEP Database and Other Programs for Processing Bioactive Peptide Sequences
Piotr Mińkiewicz, J. Dziuba, Anna Iwaniak et al. · Journal of AOAC International · 2008 · 531 citations · Full text